In the multivariable analysis, the four factors that showed a significant impact on survival (either relapse-free survival or breast cancer-specific survival) were: pathological tumor size, pathological node status, ER status, and Ki67 natural log intervals—all derived from the surgical specimen analysis. This evidence concerns the gene ESR1 and breast carcinoma.